Illumina Inc. rose as much as 8 percent to its highest level since December after a report that Thermo Fisher Scientific Inc. made a $30 billion offer for the rival maker of gene-sequencing equipment.
{iframe}http://www.bloomberg.com/news/articles/2016-08-18/illumina-gains-on-report-of-30-billion-offer-from-thermo-fisher{/iframe}